Fundraising September 15, 2024 – October 1, 2024 About fundraising

Phase I study of the anti-FcRH5 antibody-drug conjugate...

Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma

Stewart, A. Keith, Krishnan, Amrita Y., Singhal, Seema, Boccia, Ralph V., Patel, Manish R., Niesvizky, Ruben, Chanan-Khan, Asher A., Ailawadhi, Sikander, Brumm, Jochen, Mundt, Kirsten E., Hong, Kyu, M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Journal:
Blood Cancer Journal
DOI:
10.1038/s41408-019-0178-8
Date:
February, 2019
File:
PDF, 1.17 MB
2019
Conversion to is in progress
Conversion to is failed